nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulindac—CYP1A1—Propranolol—migraine	0.118	0.217	CbGbCtD
Sulindac—PTGS1—Valproic Acid—migraine	0.0927	0.171	CbGbCtD
Sulindac—SLC22A6—Valproic Acid—migraine	0.0813	0.15	CbGbCtD
Sulindac—ALB—Amitriptyline—migraine	0.076	0.14	CbGbCtD
Sulindac—CYP1A2—Propranolol—migraine	0.0526	0.0968	CbGbCtD
Sulindac—CYP1A2—Amitriptyline—migraine	0.0455	0.0837	CbGbCtD
Sulindac—CYP1A2—Valproic Acid—migraine	0.0414	0.0763	CbGbCtD
Sulindac—CYP1A2—Verapamil—migraine	0.0361	0.0664	CbGbCtD
Sulindac—AKR1B1—peripheral nervous system—migraine	0.0109	0.154	CbGeAlD
Sulindac—MAPK3—blood vessel—migraine	0.00482	0.0683	CbGeAlD
Sulindac—AKR1B1—trigeminal ganglion—migraine	0.0041	0.0582	CbGeAlD
Sulindac—MAPK3—neck—migraine	0.00345	0.0489	CbGeAlD
Sulindac—PTGDR2—cerebellum—migraine	0.00337	0.0478	CbGeAlD
Sulindac—MAPK3—trigeminal ganglion—migraine	0.00298	0.0422	CbGeAlD
Sulindac—AKR1B1—cardiovascular system—migraine	0.00296	0.042	CbGeAlD
Sulindac—PTGDR2—brain—migraine	0.00274	0.0388	CbGeAlD
Sulindac—MAPK3—cardiovascular system—migraine	0.00215	0.0305	CbGeAlD
Sulindac—AKR1B1—head—migraine	0.00201	0.0285	CbGeAlD
Sulindac—AKR1B1—nervous system—migraine	0.0019	0.027	CbGeAlD
Sulindac—AKR1B1—central nervous system—migraine	0.00183	0.026	CbGeAlD
Sulindac—AKR1B1—cerebellum—migraine	0.00179	0.0254	CbGeAlD
Sulindac—PPARD—head—migraine	0.00158	0.0224	CbGeAlD
Sulindac—PPARD—nervous system—migraine	0.0015	0.0212	CbGeAlD
Sulindac—MAPK3—head—migraine	0.00146	0.0206	CbGeAlD
Sulindac—AKR1B1—brain—migraine	0.00145	0.0206	CbGeAlD
Sulindac—PPARD—central nervous system—migraine	0.00144	0.0204	CbGeAlD
Sulindac—PPARD—cerebellum—migraine	0.00141	0.02	CbGeAlD
Sulindac—MAPK3—nervous system—migraine	0.00138	0.0196	CbGeAlD
Sulindac—MAPK3—central nervous system—migraine	0.00133	0.0188	CbGeAlD
Sulindac—PTGS1—blood vessel—migraine	0.00131	0.0186	CbGeAlD
Sulindac—MAPK3—cerebellum—migraine	0.0013	0.0184	CbGeAlD
Sulindac—PTGS2—blood vessel—migraine	0.00125	0.0177	CbGeAlD
Sulindac—PPARD—brain—migraine	0.00114	0.0162	CbGeAlD
Sulindac—MAPK3—brain—migraine	0.00105	0.015	CbGeAlD
Sulindac—SLC22A6—brain—migraine	0.000807	0.0114	CbGeAlD
Sulindac—PTGS2—trigeminal ganglion—migraine	0.000773	0.011	CbGeAlD
Sulindac—PTGS1—cardiovascular system—migraine	0.000584	0.00828	CbGeAlD
Sulindac—PPARD—NRF2 pathway—TGFBR2—migraine	0.000568	0.00445	CbGpPWpGaD
Sulindac—MAPK3—GMCSF-mediated signaling events—FOS—migraine	0.000565	0.00443	CbGpPWpGaD
Sulindac—PTGDR2—GPCR ligand binding—TAC1—migraine	0.000565	0.00443	CbGpPWpGaD
Sulindac—PTGDR2—GPCR ligand binding—NPS—migraine	0.000565	0.00443	CbGpPWpGaD
Sulindac—MAPK3—Neurotrophic factor-mediated Trk receptor signaling—BDNF—migraine	0.000561	0.0044	CbGpPWpGaD
Sulindac—PTGS2—cardiovascular system—migraine	0.000558	0.00792	CbGeAlD
Sulindac—PTGDR2—GPCR downstream signaling—HTR1D—migraine	0.000556	0.00436	CbGpPWpGaD
Sulindac—PTGDR2—GPCR ligand binding—HTR2C—migraine	0.000554	0.00434	CbGpPWpGaD
Sulindac—MAPK3—PDGF Pathway—FOS—migraine	0.000542	0.00425	CbGpPWpGaD
Sulindac—PTGDR2—GPCR ligand binding—EDNRA—migraine	0.000539	0.00422	CbGpPWpGaD
Sulindac—MAPK3—IL-5 Signaling Pathway—FOS—migraine	0.000531	0.00416	CbGpPWpGaD
Sulindac—PTGDR2—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000521	0.00408	CbGpPWpGaD
Sulindac—MAPK3—ErbB2/ErbB3 signaling events—FOS—migraine	0.000521	0.00408	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—SCN1A—migraine	0.00052	0.00408	CbGpPWpGaD
Sulindac—PTGDR2—GPCR ligand binding—CALCA—migraine	0.000519	0.00407	CbGpPWpGaD
Sulindac—PTGDR2—GPCR downstream signaling—HTR2B—migraine	0.000517	0.00405	CbGpPWpGaD
Sulindac—MAPK3—IL-2 Signaling Pathway—FOS—migraine	0.000511	0.004	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—HTR1D—migraine	0.000505	0.00396	CbGpPWpGaD
Sulindac—ALB—brain—migraine	0.000503	0.00713	CbGeAlD
Sulindac—MAPK3—FCERI mediated MAPK activation—FOS—migraine	0.000501	0.00393	CbGpPWpGaD
Sulindac—CYP1A2—Estrogen Receptor Pathway—ESR1—migraine	0.000488	0.00382	CbGpPWpGaD
Sulindac—PTGDR2—GPCR ligand binding—HTR7—migraine	0.000485	0.0038	CbGpPWpGaD
Sulindac—MAPK3—Presenilin action in Notch and Wnt signaling—FOS—migraine	0.000475	0.00372	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—HTR2B—migraine	0.000469	0.00368	CbGpPWpGaD
Sulindac—MAPK3—Structural Pathway of Interleukin 1 (IL-1)—FOS—migraine	0.000467	0.00366	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2B—migraine	0.000465	0.00365	CbGpPWpGaD
Sulindac—MAPK3—Cellular roles of Anthrax toxin—TNF—migraine	0.000461	0.00361	CbGpPWpGaD
Sulindac—MAPK3—IL-3 Signaling Pathway—FOS—migraine	0.000452	0.00354	CbGpPWpGaD
Sulindac—CYP1A1—head—migraine	0.00045	0.00638	CbGeAlD
Sulindac—Body temperature increased—Propranolol—migraine	0.000446	0.00173	CcSEcCtD
Sulindac—PTGDR2—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000446	0.0035	CbGpPWpGaD
Sulindac—Visual impairment—Timolol—migraine	0.000445	0.00172	CcSEcCtD
Sulindac—Flatulence—Valproic Acid—migraine	0.000445	0.00172	CcSEcCtD
Sulindac—Constipation—Verapamil—migraine	0.000444	0.00172	CcSEcCtD
Sulindac—Pancreatitis—Topiramate—migraine	0.000443	0.00171	CcSEcCtD
Sulindac—Tension—Valproic Acid—migraine	0.000443	0.00171	CcSEcCtD
Sulindac—MAPK3—Axon guidance—SCN2A—migraine	0.000442	0.00347	CbGpPWpGaD
Sulindac—Dysgeusia—Valproic Acid—migraine	0.000442	0.00171	CcSEcCtD
Sulindac—Vomiting—Amitriptyline—migraine	0.000441	0.0017	CcSEcCtD
Sulindac—Sweating increased—Topiramate—migraine	0.00044	0.0017	CcSEcCtD
Sulindac—Nervousness—Valproic Acid—migraine	0.000438	0.00169	CcSEcCtD
Sulindac—Rash—Amitriptyline—migraine	0.000437	0.00169	CcSEcCtD
Sulindac—Dermatitis—Amitriptyline—migraine	0.000437	0.00169	CcSEcCtD
Sulindac—Headache—Amitriptyline—migraine	0.000435	0.00168	CcSEcCtD
Sulindac—MAPK3—ATF-2 transcription factor network—ESR1—migraine	0.000432	0.00339	CbGpPWpGaD
Sulindac—Tinnitus—Timolol—migraine	0.00043	0.00166	CcSEcCtD
Sulindac—Hepatitis—Gabapentin—migraine	0.00043	0.00166	CcSEcCtD
Sulindac—Pancytopenia—Topiramate—migraine	0.000429	0.00166	CcSEcCtD
Sulindac—Feeling abnormal—Verapamil—migraine	0.000428	0.00165	CcSEcCtD
Sulindac—CYP1A1—nervous system—migraine	0.000427	0.00605	CbGeAlD
Sulindac—Vision blurred—Valproic Acid—migraine	0.000425	0.00164	CcSEcCtD
Sulindac—Dysuria—Topiramate—migraine	0.000422	0.00163	CcSEcCtD
Sulindac—Neutropenia—Topiramate—migraine	0.000422	0.00163	CcSEcCtD
Sulindac—Ill-defined disorder—Valproic Acid—migraine	0.000419	0.00162	CcSEcCtD
Sulindac—MAPK3—TGF-beta Receptor Signaling—FOS—migraine	0.000418	0.00327	CbGpPWpGaD
Sulindac—MAPK3—FGF signaling pathway—FOS—migraine	0.000418	0.00327	CbGpPWpGaD
Sulindac—MAPK3—IL2-mediated signaling events—FOS—migraine	0.000418	0.00327	CbGpPWpGaD
Sulindac—MAPK3—IL-4 Signaling Pathway—FOS—migraine	0.000418	0.00327	CbGpPWpGaD
Sulindac—Anaemia—Valproic Acid—migraine	0.000417	0.00161	CcSEcCtD
Sulindac—Hypersensitivity—Propranolol—migraine	0.000416	0.00161	CcSEcCtD
Sulindac—Visual impairment—Gabapentin—migraine	0.000414	0.0016	CcSEcCtD
Sulindac—Urticaria—Verapamil—migraine	0.000413	0.00159	CcSEcCtD
Sulindac—Angioedema—Valproic Acid—migraine	0.000412	0.00159	CcSEcCtD
Sulindac—Photosensitivity reaction—Topiramate—migraine	0.000412	0.00159	CcSEcCtD
Sulindac—Arrhythmia—Timolol—migraine	0.000412	0.00159	CcSEcCtD
Sulindac—Nausea—Amitriptyline—migraine	0.000412	0.00159	CcSEcCtD
Sulindac—MAPK3—RANKL/RANK Signaling Pathway—FOS—migraine	0.000412	0.00323	CbGpPWpGaD
Sulindac—CYP1A1—central nervous system—migraine	0.000411	0.00583	CbGeAlD
Sulindac—PTGDR2—Signaling Pathways—RAMP1—migraine	0.00041	0.00322	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—CALCRL—migraine	0.00041	0.00322	CbGpPWpGaD
Sulindac—PTGS2—Calcium signaling in the CD4+ TCR pathway—FOS—migraine	0.000409	0.0032	CbGpPWpGaD
Sulindac—Alopecia—Timolol—migraine	0.000408	0.00158	CcSEcCtD
Sulindac—Hyperglycaemia—Topiramate—migraine	0.000408	0.00157	CcSEcCtD
Sulindac—Malaise—Valproic Acid—migraine	0.000407	0.00157	CcSEcCtD
Sulindac—Erythema multiforme—Gabapentin—migraine	0.000406	0.00157	CcSEcCtD
Sulindac—MAPK3—MAP kinase activation in TLR cascade—FOS—migraine	0.000406	0.00318	CbGpPWpGaD
Sulindac—Vertigo—Valproic Acid—migraine	0.000405	0.00157	CcSEcCtD
Sulindac—Asthenia—Propranolol—migraine	0.000405	0.00157	CcSEcCtD
Sulindac—Pneumonia—Topiramate—migraine	0.000405	0.00157	CcSEcCtD
Sulindac—Leukopenia—Valproic Acid—migraine	0.000404	0.00156	CcSEcCtD
Sulindac—Depression—Topiramate—migraine	0.000402	0.00155	CcSEcCtD
Sulindac—Tinnitus—Gabapentin—migraine	0.000401	0.00155	CcSEcCtD
Sulindac—Stevens-Johnson syndrome—Topiramate—migraine	0.000399	0.00154	CcSEcCtD
Sulindac—Palpitations—Valproic Acid—migraine	0.000399	0.00154	CcSEcCtD
Sulindac—Renal failure—Topiramate—migraine	0.000396	0.00153	CcSEcCtD
Sulindac—PTGS1—head—migraine	0.000395	0.00561	CbGeAlD
Sulindac—Neuropathy peripheral—Topiramate—migraine	0.000395	0.00153	CcSEcCtD
Sulindac—Tension—Timolol—migraine	0.000394	0.00152	CcSEcCtD
Sulindac—Dysgeusia—Timolol—migraine	0.000393	0.00152	CcSEcCtD
Sulindac—Stomatitis—Topiramate—migraine	0.000393	0.00152	CcSEcCtD
Sulindac—Conjunctivitis—Topiramate—migraine	0.000392	0.00151	CcSEcCtD
Sulindac—Nervousness—Timolol—migraine	0.00039	0.00151	CcSEcCtD
Sulindac—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—migraine	0.00039	0.00306	CbGpPWpGaD
Sulindac—Hypertension—Valproic Acid—migraine	0.00039	0.00151	CcSEcCtD
Sulindac—MAPK3—Kit receptor signaling pathway—FOS—migraine	0.000389	0.00305	CbGpPWpGaD
Sulindac—MAPK3—ATF-2 transcription factor network—FOS—migraine	0.000389	0.00305	CbGpPWpGaD
Sulindac—PTGS1—Overview of nanoparticle effects—TNF—migraine	0.000388	0.00304	CbGpPWpGaD
Sulindac—Diarrhoea—Propranolol—migraine	0.000386	0.00149	CcSEcCtD
Sulindac—Chills—Gabapentin—migraine	0.000386	0.00149	CcSEcCtD
Sulindac—MAPK3—Regulation of Telomerase—ESR1—migraine	0.000386	0.00302	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—TRPM8—migraine	0.000385	0.00302	CbGpPWpGaD
Sulindac—Chest pain—Valproic Acid—migraine	0.000384	0.00148	CcSEcCtD
Sulindac—Myalgia—Valproic Acid—migraine	0.000384	0.00148	CcSEcCtD
Sulindac—Arthralgia—Valproic Acid—migraine	0.000384	0.00148	CcSEcCtD
Sulindac—Haematuria—Topiramate—migraine	0.000384	0.00148	CcSEcCtD
Sulindac—Hypersensitivity—Verapamil—migraine	0.000383	0.00148	CcSEcCtD
Sulindac—Epistaxis—Topiramate—migraine	0.00038	0.00147	CcSEcCtD
Sulindac—Alopecia—Gabapentin—migraine	0.00038	0.00147	CcSEcCtD
Sulindac—Discomfort—Valproic Acid—migraine	0.00038	0.00147	CcSEcCtD
Sulindac—MAPK3—Signaling by ERBB4—PGR—migraine	0.000379	0.00297	CbGpPWpGaD
Sulindac—MAPK3—Fc-epsilon receptor I signaling in mast cells—FOS—migraine	0.000379	0.00297	CbGpPWpGaD
Sulindac—Vision blurred—Timolol—migraine	0.000379	0.00146	CcSEcCtD
Sulindac—PTGS2—head—migraine	0.000378	0.00536	CbGeAlD
Sulindac—Agranulocytosis—Topiramate—migraine	0.000376	0.00145	CcSEcCtD
Sulindac—PTGS1—nervous system—migraine	0.000375	0.00532	CbGeAlD
Sulindac—Dizziness—Propranolol—migraine	0.000373	0.00144	CcSEcCtD
Sulindac—Asthenia—Verapamil—migraine	0.000373	0.00144	CcSEcCtD
Sulindac—MAPK3—Developmental Biology—SCN1A—migraine	0.000371	0.00291	CbGpPWpGaD
Sulindac—MAPK3—Endothelins—FOS—migraine	0.000369	0.00289	CbGpPWpGaD
Sulindac—Flatulence—Gabapentin—migraine	0.000369	0.00142	CcSEcCtD
Sulindac—Anaphylactic shock—Valproic Acid—migraine	0.000368	0.00142	CcSEcCtD
Sulindac—Oedema—Valproic Acid—migraine	0.000368	0.00142	CcSEcCtD
Sulindac—Pruritus—Verapamil—migraine	0.000368	0.00142	CcSEcCtD
Sulindac—Tension—Gabapentin—migraine	0.000367	0.00142	CcSEcCtD
Sulindac—Angioedema—Timolol—migraine	0.000367	0.00142	CcSEcCtD
Sulindac—Dysgeusia—Gabapentin—migraine	0.000366	0.00142	CcSEcCtD
Sulindac—Nervousness—Gabapentin—migraine	0.000363	0.0014	CcSEcCtD
Sulindac—Hepatitis—Topiramate—migraine	0.000362	0.0014	CcSEcCtD
Sulindac—Vertigo—Timolol—migraine	0.000361	0.0014	CcSEcCtD
Sulindac—PTGS1—central nervous system—migraine	0.000361	0.00512	CbGeAlD
Sulindac—Thrombocytopenia—Valproic Acid—migraine	0.000361	0.00139	CcSEcCtD
Sulindac—Syncope—Timolol—migraine	0.00036	0.00139	CcSEcCtD
Sulindac—MAPK3—Oncostatin M Signaling Pathway—FOS—migraine	0.00036	0.00282	CbGpPWpGaD
Sulindac—Tachycardia—Valproic Acid—migraine	0.000359	0.00139	CcSEcCtD
Sulindac—Vomiting—Propranolol—migraine	0.000359	0.00139	CcSEcCtD
Sulindac—PTGS2—nervous system—migraine	0.000358	0.00508	CbGeAlD
Sulindac—MAPK3—Leptin signaling pathway—ESR1—migraine	0.000356	0.00279	CbGpPWpGaD
Sulindac—Hyperhidrosis—Valproic Acid—migraine	0.000356	0.00138	CcSEcCtD
Sulindac—Rash—Propranolol—migraine	0.000356	0.00138	CcSEcCtD
Sulindac—MAPK3—TSH signaling pathway—FOS—migraine	0.000356	0.00279	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling in naïve CD8+ T cells—FOS—migraine	0.000356	0.00279	CbGpPWpGaD
Sulindac—Dermatitis—Propranolol—migraine	0.000356	0.00137	CcSEcCtD
Sulindac—Diarrhoea—Verapamil—migraine	0.000355	0.00137	CcSEcCtD
Sulindac—Palpitations—Timolol—migraine	0.000355	0.00137	CcSEcCtD
Sulindac—Loss of consciousness—Timolol—migraine	0.000353	0.00136	CcSEcCtD
Sulindac—CYP1A1—Oxidative Stress—FOS—migraine	0.000353	0.00277	CbGpPWpGaD
Sulindac—Vision blurred—Gabapentin—migraine	0.000353	0.00136	CcSEcCtD
Sulindac—MAPK3—BCR signaling pathway—FOS—migraine	0.000352	0.00276	CbGpPWpGaD
Sulindac—Anorexia—Valproic Acid—migraine	0.000351	0.00136	CcSEcCtD
Sulindac—Visual impairment—Topiramate—migraine	0.000348	0.00135	CcSEcCtD
Sulindac—MAPK3—Regulation of Telomerase—FOS—migraine	0.000347	0.00272	CbGpPWpGaD
Sulindac—Ill-defined disorder—Gabapentin—migraine	0.000347	0.00134	CcSEcCtD
Sulindac—Hypertension—Timolol—migraine	0.000347	0.00134	CcSEcCtD
Sulindac—Anaemia—Gabapentin—migraine	0.000346	0.00134	CcSEcCtD
Sulindac—PTGS2—central nervous system—migraine	0.000345	0.00489	CbGeAlD
Sulindac—Hypotension—Valproic Acid—migraine	0.000344	0.00133	CcSEcCtD
Sulindac—Dizziness—Verapamil—migraine	0.000344	0.00133	CcSEcCtD
Sulindac—Arthralgia—Timolol—migraine	0.000342	0.00132	CcSEcCtD
Sulindac—Chest pain—Timolol—migraine	0.000342	0.00132	CcSEcCtD
Sulindac—Myalgia—Timolol—migraine	0.000342	0.00132	CcSEcCtD
Sulindac—Erythema multiforme—Topiramate—migraine	0.000342	0.00132	CcSEcCtD
Sulindac—Angioedema—Gabapentin—migraine	0.000342	0.00132	CcSEcCtD
Sulindac—PTGDR2—GPCR ligand binding—HTR2A—migraine	0.00034	0.00266	CbGpPWpGaD
Sulindac—Discomfort—Timolol—migraine	0.000338	0.00131	CcSEcCtD
Sulindac—Malaise—Gabapentin—migraine	0.000337	0.0013	CcSEcCtD
Sulindac—PTGS2—cerebellum—migraine	0.000337	0.00478	CbGeAlD
Sulindac—Tinnitus—Topiramate—migraine	0.000337	0.0013	CcSEcCtD
Sulindac—PTGDR2—GPCR downstream signaling—HTR1B—migraine	0.000337	0.00264	CbGpPWpGaD
Sulindac—PPARD—Generic Transcription Pathway—NOTCH4—migraine	0.000336	0.00264	CbGpPWpGaD
Sulindac—Vertigo—Gabapentin—migraine	0.000336	0.0013	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Valproic Acid—migraine	0.000336	0.0013	CcSEcCtD
Sulindac—Flushing—Topiramate—migraine	0.000336	0.0013	CcSEcCtD
Sulindac—Syncope—Gabapentin—migraine	0.000336	0.0013	CcSEcCtD
Sulindac—Nausea—Propranolol—migraine	0.000335	0.0013	CcSEcCtD
Sulindac—Leukopenia—Gabapentin—migraine	0.000335	0.00129	CcSEcCtD
Sulindac—Insomnia—Valproic Acid—migraine	0.000333	0.00129	CcSEcCtD
Sulindac—MAPK3—Spinal Cord Injury—BDNF—migraine	0.000331	0.00259	CbGpPWpGaD
Sulindac—Paraesthesia—Valproic Acid—migraine	0.000331	0.00128	CcSEcCtD
Sulindac—Palpitations—Gabapentin—migraine	0.000331	0.00128	CcSEcCtD
Sulindac—Vomiting—Verapamil—migraine	0.00033	0.00128	CcSEcCtD
Sulindac—Loss of consciousness—Gabapentin—migraine	0.000329	0.00127	CcSEcCtD
Sulindac—Dyspnoea—Valproic Acid—migraine	0.000328	0.00127	CcSEcCtD
Sulindac—Oedema—Timolol—migraine	0.000328	0.00127	CcSEcCtD
Sulindac—Anaphylactic shock—Timolol—migraine	0.000328	0.00127	CcSEcCtD
Sulindac—Rash—Verapamil—migraine	0.000328	0.00127	CcSEcCtD
Sulindac—Somnolence—Valproic Acid—migraine	0.000327	0.00127	CcSEcCtD
Sulindac—Dermatitis—Verapamil—migraine	0.000327	0.00126	CcSEcCtD
Sulindac—CYP1A1—brain—migraine	0.000326	0.00463	CbGeAlD
Sulindac—Headache—Verapamil—migraine	0.000325	0.00126	CcSEcCtD
Sulindac—Chills—Topiramate—migraine	0.000324	0.00125	CcSEcCtD
Sulindac—Dyspepsia—Valproic Acid—migraine	0.000324	0.00125	CcSEcCtD
Sulindac—PTGDR2—GPCR downstream signaling—HTR1A—migraine	0.000324	0.00254	CbGpPWpGaD
Sulindac—Convulsion—Gabapentin—migraine	0.000324	0.00125	CcSEcCtD
Sulindac—Hypertension—Gabapentin—migraine	0.000323	0.00125	CcSEcCtD
Sulindac—Shock—Timolol—migraine	0.000323	0.00125	CcSEcCtD
Sulindac—MAPK3—TRAF6 Mediated Induction of proinflammatory cytokines—FOS—migraine	0.000321	0.00252	CbGpPWpGaD
Sulindac—Decreased appetite—Valproic Acid—migraine	0.00032	0.00124	CcSEcCtD
Sulindac—Alopecia—Topiramate—migraine	0.00032	0.00123	CcSEcCtD
Sulindac—PTGDR2—GPCR downstream signaling—TAC1—migraine	0.000319	0.0025	CbGpPWpGaD
Sulindac—PTGDR2—GPCR downstream signaling—NPS—migraine	0.000319	0.0025	CbGpPWpGaD
Sulindac—Arthralgia—Gabapentin—migraine	0.000319	0.00123	CcSEcCtD
Sulindac—Myalgia—Gabapentin—migraine	0.000319	0.00123	CcSEcCtD
Sulindac—Chest pain—Gabapentin—migraine	0.000319	0.00123	CcSEcCtD
Sulindac—Fatigue—Valproic Acid—migraine	0.000318	0.00123	CcSEcCtD
Sulindac—Hyperhidrosis—Timolol—migraine	0.000317	0.00123	CcSEcCtD
Sulindac—MAPK3—Developmental Biology—SCN2A—migraine	0.000316	0.00247	CbGpPWpGaD
Sulindac—Constipation—Valproic Acid—migraine	0.000315	0.00122	CcSEcCtD
Sulindac—Discomfort—Gabapentin—migraine	0.000315	0.00122	CcSEcCtD
Sulindac—PTGS2—Aryl Hydrocarbon Receptor—ESR1—migraine	0.000313	0.00246	CbGpPWpGaD
Sulindac—PTGDR2—GPCR downstream signaling—HTR2C—migraine	0.000313	0.00245	CbGpPWpGaD
Sulindac—Anorexia—Timolol—migraine	0.000313	0.00121	CcSEcCtD
Sulindac—Flatulence—Topiramate—migraine	0.00031	0.0012	CcSEcCtD
Sulindac—Tension—Topiramate—migraine	0.000309	0.00119	CcSEcCtD
Sulindac—Nausea—Verapamil—migraine	0.000309	0.00119	CcSEcCtD
Sulindac—Dysgeusia—Topiramate—migraine	0.000308	0.00119	CcSEcCtD
Sulindac—PTGS2—Overview of nanoparticle effects—TNF—migraine	0.000308	0.00241	CbGpPWpGaD
Sulindac—PPARD—Generic Transcription Pathway—PGR—migraine	0.000308	0.00241	CbGpPWpGaD
Sulindac—Hypotension—Timolol—migraine	0.000306	0.00118	CcSEcCtD
Sulindac—PTGDR2—Signaling by GPCR—HTR1B—migraine	0.000306	0.0024	CbGpPWpGaD
Sulindac—Nervousness—Topiramate—migraine	0.000306	0.00118	CcSEcCtD
Sulindac—Oedema—Gabapentin—migraine	0.000305	0.00118	CcSEcCtD
Sulindac—Anaphylactic shock—Gabapentin—migraine	0.000305	0.00118	CcSEcCtD
Sulindac—PTGDR2—GPCR downstream signaling—EDNRA—migraine	0.000305	0.00239	CbGpPWpGaD
Sulindac—Feeling abnormal—Valproic Acid—migraine	0.000304	0.00117	CcSEcCtD
Sulindac—Gastrointestinal pain—Valproic Acid—migraine	0.000301	0.00116	CcSEcCtD
Sulindac—Shock—Gabapentin—migraine	0.0003	0.00116	CcSEcCtD
Sulindac—MAPK3—Glucocorticoid receptor regulatory network—FOS—migraine	0.000299	0.00234	CbGpPWpGaD
Sulindac—Thrombocytopenia—Gabapentin—migraine	0.000299	0.00116	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Timolol—migraine	0.000299	0.00115	CcSEcCtD
Sulindac—PTGDR2—Signaling Pathways—HTR1D—migraine	0.000298	0.00234	CbGpPWpGaD
Sulindac—Tachycardia—Gabapentin—migraine	0.000298	0.00115	CcSEcCtD
Sulindac—Vision blurred—Topiramate—migraine	0.000297	0.00115	CcSEcCtD
Sulindac—Insomnia—Timolol—migraine	0.000297	0.00115	CcSEcCtD
Sulindac—Hyperhidrosis—Gabapentin—migraine	0.000295	0.00114	CcSEcCtD
Sulindac—Paraesthesia—Timolol—migraine	0.000294	0.00114	CcSEcCtD
Sulindac—PTGDR2—Signaling by GPCR—HTR1A—migraine	0.000294	0.00231	CbGpPWpGaD
Sulindac—PTGDR2—GPCR downstream signaling—CALCA—migraine	0.000293	0.0023	CbGpPWpGaD
Sulindac—Urticaria—Valproic Acid—migraine	0.000293	0.00113	CcSEcCtD
Sulindac—Dyspnoea—Timolol—migraine	0.000292	0.00113	CcSEcCtD
Sulindac—Ill-defined disorder—Topiramate—migraine	0.000292	0.00113	CcSEcCtD
Sulindac—SLC22A6—Transmembrane transport of small molecules—ATP1A3—migraine	0.000292	0.00229	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—ATP1A2—migraine	0.000292	0.00229	CbGpPWpGaD
Sulindac—Somnolence—Timolol—migraine	0.000292	0.00113	CcSEcCtD
Sulindac—Body temperature increased—Valproic Acid—migraine	0.000291	0.00113	CcSEcCtD
Sulindac—Anorexia—Gabapentin—migraine	0.000291	0.00112	CcSEcCtD
Sulindac—Anaemia—Topiramate—migraine	0.000291	0.00112	CcSEcCtD
Sulindac—MAPK3—MyD88 cascade initiated on plasma membrane—FOS—migraine	0.000291	0.00228	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—NPS—migraine	0.00029	0.00227	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—TAC1—migraine	0.00029	0.00227	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—MEF2D—migraine	0.000289	0.00226	CbGpPWpGaD
Sulindac—Dyspepsia—Timolol—migraine	0.000289	0.00112	CcSEcCtD
Sulindac—MAPK3—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—FOS—migraine	0.000288	0.00226	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.000288	0.00225	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.000288	0.00225	CbGpPWpGaD
Sulindac—PTGS1—brain—migraine	0.000287	0.00406	CbGeAlD
Sulindac—PPARD—Generic Transcription Pathway—NOTCH3—migraine	0.000286	0.00224	CbGpPWpGaD
Sulindac—Hypotension—Gabapentin—migraine	0.000285	0.0011	CcSEcCtD
Sulindac—Decreased appetite—Timolol—migraine	0.000285	0.0011	CcSEcCtD
Sulindac—PTGDR2—Signaling by GPCR—HTR2C—migraine	0.000284	0.00223	CbGpPWpGaD
Sulindac—Malaise—Topiramate—migraine	0.000284	0.0011	CcSEcCtD
Sulindac—Vertigo—Topiramate—migraine	0.000283	0.00109	CcSEcCtD
Sulindac—MAPK3—MyD88 dependent cascade initiated on endosome—FOS—migraine	0.000283	0.00222	CbGpPWpGaD
Sulindac—Fatigue—Timolol—migraine	0.000283	0.00109	CcSEcCtD
Sulindac—Syncope—Topiramate—migraine	0.000282	0.00109	CcSEcCtD
Sulindac—MAPK3—BDNF signaling pathway—BDNF—migraine	0.000282	0.00221	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.000282	0.00221	CbGpPWpGaD
Sulindac—Leukopenia—Topiramate—migraine	0.000282	0.00109	CcSEcCtD
Sulindac—CYP1A1—Aryl Hydrocarbon Receptor—ESR1—migraine	0.000278	0.00218	CbGpPWpGaD
Sulindac—Musculoskeletal discomfort—Gabapentin—migraine	0.000278	0.00108	CcSEcCtD
Sulindac—Palpitations—Topiramate—migraine	0.000278	0.00108	CcSEcCtD
Sulindac—MAPK3—TCR Signaling Pathway—FOS—migraine	0.000278	0.00218	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—HTR2B—migraine	0.000277	0.00217	CbGpPWpGaD
Sulindac—Loss of consciousness—Topiramate—migraine	0.000277	0.00107	CcSEcCtD
Sulindac—PTGDR2—Signaling by GPCR—EDNRA—migraine	0.000277	0.00217	CbGpPWpGaD
Sulindac—Insomnia—Gabapentin—migraine	0.000276	0.00107	CcSEcCtD
Sulindac—MAPK3—Apoptosis Modulation and Signaling—FOS—migraine	0.000275	0.00216	CbGpPWpGaD
Sulindac—MAPK3—TWEAK Signaling Pathway—TNF—migraine	0.000275	0.00215	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.000274	0.00215	CbGpPWpGaD
Sulindac—PTGDR2—GPCR downstream signaling—HTR7—migraine	0.000274	0.00215	CbGpPWpGaD
Sulindac—Paraesthesia—Gabapentin—migraine	0.000274	0.00106	CcSEcCtD
Sulindac—PTGS2—brain—migraine	0.000274	0.00389	CbGeAlD
Sulindac—MAPK3—Corticotropin-releasing hormone—FOS—migraine	0.000273	0.00214	CbGpPWpGaD
Sulindac—MAPK3—Toll Like Receptor 9 (TLR9) Cascade—FOS—migraine	0.000273	0.00214	CbGpPWpGaD
Sulindac—Convulsion—Topiramate—migraine	0.000273	0.00105	CcSEcCtD
Sulindac—Dyspnoea—Gabapentin—migraine	0.000272	0.00105	CcSEcCtD
Sulindac—Hypertension—Topiramate—migraine	0.000272	0.00105	CcSEcCtD
Sulindac—Somnolence—Gabapentin—migraine	0.000271	0.00105	CcSEcCtD
Sulindac—Hypersensitivity—Valproic Acid—migraine	0.000271	0.00105	CcSEcCtD
Sulindac—Feeling abnormal—Timolol—migraine	0.00027	0.00104	CcSEcCtD
Sulindac—Dyspepsia—Gabapentin—migraine	0.000269	0.00104	CcSEcCtD
Sulindac—MAPK3—MyD88:Mal cascade initiated on plasma membrane—FOS—migraine	0.000268	0.0021	CbGpPWpGaD
Sulindac—Gastrointestinal pain—Timolol—migraine	0.000268	0.00104	CcSEcCtD
Sulindac—Chest pain—Topiramate—migraine	0.000268	0.00104	CcSEcCtD
Sulindac—Arthralgia—Topiramate—migraine	0.000268	0.00104	CcSEcCtD
Sulindac—Myalgia—Topiramate—migraine	0.000268	0.00104	CcSEcCtD
Sulindac—PTGDR2—Signaling by GPCR—CALCA—migraine	0.000266	0.00209	CbGpPWpGaD
Sulindac—Decreased appetite—Gabapentin—migraine	0.000265	0.00103	CcSEcCtD
Sulindac—Discomfort—Topiramate—migraine	0.000265	0.00102	CcSEcCtD
Sulindac—PTGS1—Selenium Micronutrient Network—MTHFR—migraine	0.000264	0.00207	CbGpPWpGaD
Sulindac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOS—migraine	0.000264	0.00207	CbGpPWpGaD
Sulindac—Asthenia—Valproic Acid—migraine	0.000264	0.00102	CcSEcCtD
Sulindac—Fatigue—Gabapentin—migraine	0.000263	0.00102	CcSEcCtD
Sulindac—ALB—Vitamin B12 Metabolism—MTHFR—migraine	0.000263	0.00206	CbGpPWpGaD
Sulindac—Constipation—Gabapentin—migraine	0.000261	0.00101	CcSEcCtD
Sulindac—Pruritus—Valproic Acid—migraine	0.000261	0.00101	CcSEcCtD
Sulindac—Urticaria—Timolol—migraine	0.00026	0.00101	CcSEcCtD
Sulindac—Body temperature increased—Timolol—migraine	0.000259	0.001	CcSEcCtD
Sulindac—MAPK3—MAPK Signaling Pathway—TGFBR2—migraine	0.000259	0.00203	CbGpPWpGaD
Sulindac—MAPK3—MyD88-independent cascade—FOS—migraine	0.000257	0.00202	CbGpPWpGaD
Sulindac—Oedema—Topiramate—migraine	0.000257	0.000993	CcSEcCtD
Sulindac—Shock—Topiramate—migraine	0.000253	0.000977	CcSEcCtD
Sulindac—Diarrhoea—Valproic Acid—migraine	0.000252	0.000974	CcSEcCtD
Sulindac—Feeling abnormal—Gabapentin—migraine	0.000252	0.000972	CcSEcCtD
Sulindac—Thrombocytopenia—Topiramate—migraine	0.000252	0.000972	CcSEcCtD
Sulindac—MAPK3—Toll-like Receptor Signaling Pathway—FOS—migraine	0.000251	0.00197	CbGpPWpGaD
Sulindac—Tachycardia—Topiramate—migraine	0.000251	0.000969	CcSEcCtD
Sulindac—Gastrointestinal pain—Gabapentin—migraine	0.00025	0.000965	CcSEcCtD
Sulindac—MAPK3—MAPK Signaling Pathway—BDNF—migraine	0.000249	0.00195	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—HTR7—migraine	0.000249	0.00195	CbGpPWpGaD
Sulindac—Hyperhidrosis—Topiramate—migraine	0.000248	0.00096	CcSEcCtD
Sulindac—SLC22A6—Transmembrane transport of small molecules—HTR3A—migraine	0.000248	0.00194	CbGpPWpGaD
Sulindac—MAPK3—Ceramide signaling pathway—TNF—migraine	0.000247	0.00193	CbGpPWpGaD
Sulindac—MAPK3—Senescence-Associated Secretory Phenotype (SASP)—FOS—migraine	0.000245	0.00192	CbGpPWpGaD
Sulindac—MAPK3—ErbB1 downstream signaling—FOS—migraine	0.000245	0.00192	CbGpPWpGaD
Sulindac—Anorexia—Topiramate—migraine	0.000245	0.000946	CcSEcCtD
Sulindac—PTGDR2—Signaling Pathways—LRP1—migraine	0.000244	0.00191	CbGpPWpGaD
Sulindac—Dizziness—Valproic Acid—migraine	0.000244	0.000941	CcSEcCtD
Sulindac—Urticaria—Gabapentin—migraine	0.000243	0.000938	CcSEcCtD
Sulindac—Hypersensitivity—Timolol—migraine	0.000242	0.000934	CcSEcCtD
Sulindac—Body temperature increased—Gabapentin—migraine	0.000241	0.000933	CcSEcCtD
Sulindac—Hypotension—Topiramate—migraine	0.00024	0.000928	CcSEcCtD
Sulindac—MAPK3—Angiopoietin receptor Tie2-mediated signaling—TNF—migraine	0.000239	0.00187	CbGpPWpGaD
Sulindac—Asthenia—Timolol—migraine	0.000235	0.000909	CcSEcCtD
Sulindac—Vomiting—Valproic Acid—migraine	0.000234	0.000905	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Topiramate—migraine	0.000234	0.000905	CcSEcCtD
Sulindac—Insomnia—Topiramate—migraine	0.000232	0.000898	CcSEcCtD
Sulindac—Rash—Valproic Acid—migraine	0.000232	0.000898	CcSEcCtD
Sulindac—Dermatitis—Valproic Acid—migraine	0.000232	0.000897	CcSEcCtD
Sulindac—Pruritus—Timolol—migraine	0.000232	0.000897	CcSEcCtD
Sulindac—MAPK3—Activated TLR4 signalling—FOS—migraine	0.000231	0.00181	CbGpPWpGaD
Sulindac—Headache—Valproic Acid—migraine	0.000231	0.000892	CcSEcCtD
Sulindac—Paraesthesia—Topiramate—migraine	0.000231	0.000892	CcSEcCtD
Sulindac—Dyspnoea—Topiramate—migraine	0.000229	0.000885	CcSEcCtD
Sulindac—Somnolence—Topiramate—migraine	0.000228	0.000883	CcSEcCtD
Sulindac—Dyspepsia—Topiramate—migraine	0.000226	0.000874	CcSEcCtD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—BDNF—migraine	0.000225	0.00176	CbGpPWpGaD
Sulindac—Hypersensitivity—Gabapentin—migraine	0.000225	0.000869	CcSEcCtD
Sulindac—MAPK3—TGF-beta Receptor Signaling—TNF—migraine	0.000225	0.00176	CbGpPWpGaD
Sulindac—Diarrhoea—Timolol—migraine	0.000224	0.000867	CcSEcCtD
Sulindac—MAPK3—Spinal Cord Injury—FOS—migraine	0.000224	0.00175	CbGpPWpGaD
Sulindac—Decreased appetite—Topiramate—migraine	0.000223	0.000863	CcSEcCtD
Sulindac—MAPK3—Oxidative Stress Induced Senescence—FOS—migraine	0.000222	0.00174	CbGpPWpGaD
Sulindac—Fatigue—Topiramate—migraine	0.000221	0.000856	CcSEcCtD
Sulindac—MAPK3—Cardiac Hypertrophic Response—TNF—migraine	0.000221	0.00173	CbGpPWpGaD
Sulindac—Constipation—Topiramate—migraine	0.00022	0.000849	CcSEcCtD
Sulindac—Asthenia—Gabapentin—migraine	0.000219	0.000847	CcSEcCtD
Sulindac—Nausea—Valproic Acid—migraine	0.000219	0.000846	CcSEcCtD
Sulindac—PPARD—Adipogenesis—TNF—migraine	0.000218	0.00171	CbGpPWpGaD
Sulindac—MAPK3—Toll Like Receptor 4 (TLR4) Cascade—FOS—migraine	0.000218	0.00171	CbGpPWpGaD
Sulindac—Dizziness—Timolol—migraine	0.000217	0.000838	CcSEcCtD
Sulindac—Pruritus—Gabapentin—migraine	0.000216	0.000835	CcSEcCtD
Sulindac—ALB—Folate Metabolism—MTHFR—migraine	0.000214	0.00168	CbGpPWpGaD
Sulindac—MAPK3—PDGFR-beta signaling pathway—FOS—migraine	0.000214	0.00167	CbGpPWpGaD
Sulindac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—migraine	0.000212	0.00166	CbGpPWpGaD
Sulindac—Feeling abnormal—Topiramate—migraine	0.000212	0.000818	CcSEcCtD
Sulindac—Gastrointestinal pain—Topiramate—migraine	0.00021	0.000812	CcSEcCtD
Sulindac—PTGS2—Selenium Micronutrient Network—MTHFR—migraine	0.00021	0.00165	CbGpPWpGaD
Sulindac—PPARD—Metabolism—CACNA1A—migraine	0.000209	0.00164	CbGpPWpGaD
Sulindac—Diarrhoea—Gabapentin—migraine	0.000209	0.000807	CcSEcCtD
Sulindac—Vomiting—Timolol—migraine	0.000208	0.000806	CcSEcCtD
Sulindac—Rash—Timolol—migraine	0.000207	0.000799	CcSEcCtD
Sulindac—Dermatitis—Timolol—migraine	0.000207	0.000798	CcSEcCtD
Sulindac—Headache—Timolol—migraine	0.000205	0.000794	CcSEcCtD
Sulindac—Urticaria—Topiramate—migraine	0.000204	0.000789	CcSEcCtD
Sulindac—Body temperature increased—Topiramate—migraine	0.000203	0.000785	CcSEcCtD
Sulindac—MAPK3—Signaling by ERBB4—ESR1—migraine	0.000203	0.00159	CbGpPWpGaD
Sulindac—Dizziness—Gabapentin—migraine	0.000202	0.00078	CcSEcCtD
Sulindac—ALB—Transmembrane transport of small molecules—TRPM8—migraine	0.0002	0.00157	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—RAMP1—migraine	0.000199	0.00156	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—CALCRL—migraine	0.000199	0.00156	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—BDNF—migraine	0.000197	0.00154	CbGpPWpGaD
Sulindac—MAPK3—Regulation of toll-like receptor signaling pathway—FOS—migraine	0.000196	0.00154	CbGpPWpGaD
Sulindac—Nausea—Timolol—migraine	0.000195	0.000753	CcSEcCtD
Sulindac—Vomiting—Gabapentin—migraine	0.000194	0.00075	CcSEcCtD
Sulindac—MAPK3—Toll-Like Receptors Cascades—FOS—migraine	0.000194	0.00152	CbGpPWpGaD
Sulindac—Rash—Gabapentin—migraine	0.000193	0.000744	CcSEcCtD
Sulindac—Dermatitis—Gabapentin—migraine	0.000192	0.000743	CcSEcCtD
Sulindac—PTGDR2—GPCR downstream signaling—HTR2A—migraine	0.000192	0.00151	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling in naïve CD8+ T cells—TNF—migraine	0.000191	0.0015	CbGpPWpGaD
Sulindac—Headache—Gabapentin—migraine	0.000191	0.000739	CcSEcCtD
Sulindac—AKR1B1—Metabolism—MTHFR—migraine	0.000191	0.0015	CbGpPWpGaD
Sulindac—MAPK3—BDNF signaling pathway—FOS—migraine	0.000191	0.00149	CbGpPWpGaD
Sulindac—Hypersensitivity—Topiramate—migraine	0.000189	0.000731	CcSEcCtD
Sulindac—PTGDR2—Signaling Pathways—NOTCH4—migraine	0.000187	0.00147	CbGpPWpGaD
Sulindac—Asthenia—Topiramate—migraine	0.000184	0.000712	CcSEcCtD
Sulindac—Pruritus—Topiramate—migraine	0.000182	0.000702	CcSEcCtD
Sulindac—Nausea—Gabapentin—migraine	0.000181	0.000701	CcSEcCtD
Sulindac—PTGDR2—Signaling Pathways—HTR1B—migraine	0.000181	0.00142	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—migraine	0.000177	0.00139	CbGpPWpGaD
Sulindac—Diarrhoea—Topiramate—migraine	0.000176	0.000679	CcSEcCtD
Sulindac—MAPK3—Insulin Signaling—FOS—migraine	0.000175	0.00137	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—HTR2A—migraine	0.000174	0.00137	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—HTR1A—migraine	0.000174	0.00136	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.000173	0.00136	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—PGR—migraine	0.000171	0.00134	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—TAC1—migraine	0.000171	0.00134	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—NPS—migraine	0.000171	0.00134	CbGpPWpGaD
Sulindac—Dizziness—Topiramate—migraine	0.00017	0.000657	CcSEcCtD
Sulindac—ALB—Selenium Micronutrient Network—MTHFR—migraine	0.00017	0.00133	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—ESR1—migraine	0.000169	0.00132	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—FOS—migraine	0.000169	0.00132	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—HTR2C—migraine	0.000168	0.00132	CbGpPWpGaD
Sulindac—MAPK3—Alzheimers Disease—TNF—migraine	0.000166	0.0013	CbGpPWpGaD
Sulindac—PPARD—Generic Transcription Pathway—ESR1—migraine	0.000164	0.00129	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—EDNRA—migraine	0.000163	0.00128	CbGpPWpGaD
Sulindac—Vomiting—Topiramate—migraine	0.000163	0.000631	CcSEcCtD
Sulindac—Rash—Topiramate—migraine	0.000162	0.000626	CcSEcCtD
Sulindac—PPARD—Gene Expression—NOTCH4—migraine	0.000162	0.00127	CbGpPWpGaD
Sulindac—Dermatitis—Topiramate—migraine	0.000162	0.000625	CcSEcCtD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—FOS—migraine	0.000162	0.00127	CbGpPWpGaD
Sulindac—Headache—Topiramate—migraine	0.000161	0.000622	CcSEcCtD
Sulindac—PTGDR2—Signaling Pathways—NOTCH3—migraine	0.000159	0.00125	CbGpPWpGaD
Sulindac—MAPK3—MicroRNAs in cardiomyocyte hypertrophy—TNF—migraine	0.000158	0.00124	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—CALCA—migraine	0.000157	0.00123	CbGpPWpGaD
Sulindac—MAPK3—Cellular Senescence—FOS—migraine	0.000155	0.00122	CbGpPWpGaD
Sulindac—Nausea—Topiramate—migraine	0.000153	0.00059	CcSEcCtD
Sulindac—PTGS2—Aryl Hydrocarbon Receptor—TNF—migraine	0.000152	0.00119	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—ATP1A3—migraine	0.000152	0.00119	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—ATP1A2—migraine	0.000152	0.00119	CbGpPWpGaD
Sulindac—PPARD—Gene Expression—PGR—migraine	0.000148	0.00116	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—HTR7—migraine	0.000147	0.00115	CbGpPWpGaD
Sulindac—MAPK3—TNF alpha Signaling Pathway—TNF—migraine	0.000147	0.00115	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—HTR1D—migraine	0.000145	0.00114	CbGpPWpGaD
Sulindac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—migraine	0.000142	0.00111	CbGpPWpGaD
Sulindac—PPARD—Gene Expression—NOTCH3—migraine	0.000138	0.00108	CbGpPWpGaD
Sulindac—MAPK3—Toll-like Receptor Signaling Pathway—TNF—migraine	0.000135	0.00106	CbGpPWpGaD
Sulindac—CYP1A1—Aryl Hydrocarbon Receptor—TNF—migraine	0.000135	0.00106	CbGpPWpGaD
Sulindac—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	0.000135	0.00106	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—HTR2B—migraine	0.000135	0.00106	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—migraine	0.000134	0.00105	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—FOS—migraine	0.000133	0.00104	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—HTR3A—migraine	0.000129	0.00101	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—TGFBR2—migraine	0.000127	0.000993	CbGpPWpGaD
Sulindac—MAPK3—Spinal Cord Injury—TNF—migraine	0.00012	0.000942	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CALCRL—migraine	0.000118	0.000923	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—RAMP1—migraine	0.000118	0.000923	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—FOS—migraine	0.000117	0.00092	CbGpPWpGaD
Sulindac—PTGS1—Selenium Micronutrient Network—TNF—migraine	0.000114	0.000892	CbGpPWpGaD
Sulindac—ALB—Vitamin B12 Metabolism—TNF—migraine	0.000113	0.000887	CbGpPWpGaD
Sulindac—MAPK3—Regulation of toll-like receptor signaling pathway—TNF—migraine	0.000105	0.000826	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—HTR2A—migraine	0.000103	0.000807	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—migraine	0.0001	0.000787	CbGpPWpGaD
Sulindac—MAPK3—Disease—LRP1—migraine	0.0001	0.000784	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—TNF—migraine	9.21e-05	0.000721	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—ESR1—migraine	9.14e-05	0.000717	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—TNF—migraine	9.06e-05	0.00071	CbGpPWpGaD
Sulindac—PTGS2—Selenium Micronutrient Network—TNF—migraine	9.04e-05	0.000708	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—HTR1B—migraine	8.78e-05	0.000688	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor—TNF—migraine	8.59e-05	0.000674	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	8.59e-05	0.000674	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—HTR1D—migraine	8.56e-05	0.000671	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—HTR1A—migraine	8.45e-05	0.000662	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—TAC1—migraine	8.32e-05	0.000652	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—NPS—migraine	8.32e-05	0.000652	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—NOTCH4—migraine	8.26e-05	0.000648	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—TNF—migraine	8.18e-05	0.000641	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—HTR2C—migraine	8.16e-05	0.000639	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—CACNA1A—migraine	8e-05	0.000627	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—HTR2B—migraine	7.96e-05	0.000623	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—EDNRA—migraine	7.94e-05	0.000622	CbGpPWpGaD
Sulindac—PPARD—Gene Expression—ESR1—migraine	7.91e-05	0.00062	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—CALCA—migraine	7.64e-05	0.000599	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—PGR—migraine	7.56e-05	0.000592	CbGpPWpGaD
Sulindac—ALB—Selenium Micronutrient Network—TNF—migraine	7.31e-05	0.000573	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—TNF—migraine	7.15e-05	0.00056	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—HTR7—migraine	7.15e-05	0.00056	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—NOTCH3—migraine	7.03e-05	0.000551	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—LRP1—migraine	7e-05	0.000549	CbGpPWpGaD
Sulindac—PPARD—Metabolism—MTHFR—migraine	6.92e-05	0.000542	CbGpPWpGaD
Sulindac—MAPK3—Disease—CALCA—migraine	6.45e-05	0.000505	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CACNA1A—migraine	6.35e-05	0.000498	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—FOS—migraine	6.28e-05	0.000492	CbGpPWpGaD
Sulindac—PTGS2—Disease—LRP1—migraine	5.95e-05	0.000466	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CACNA1A—migraine	5.63e-05	0.000442	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NOTCH4—migraine	5.37e-05	0.000421	CbGpPWpGaD
Sulindac—MAPK3—Disease—TGFBR2—migraine	5.19e-05	0.000407	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—HTR1B—migraine	5.18e-05	0.000406	CbGpPWpGaD
Sulindac—ALB—Metabolism—CACNA1A—migraine	5.14e-05	0.000403	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—HTR2A—migraine	5.01e-05	0.000392	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—HTR1A—migraine	4.99e-05	0.000391	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—PGR—migraine	4.91e-05	0.000385	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NPS—migraine	4.91e-05	0.000385	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TAC1—migraine	4.91e-05	0.000385	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—migraine	4.86e-05	0.000381	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—HTR2C—migraine	4.82e-05	0.000378	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—EDNRA—migraine	4.69e-05	0.000367	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NOTCH3—migraine	4.57e-05	0.000358	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CALCA—migraine	4.51e-05	0.000354	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—HTR7—migraine	4.22e-05	0.000331	CbGpPWpGaD
Sulindac—MAPK3—Disease—MTHFR—migraine	4.22e-05	0.00033	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—ESR1—migraine	4.04e-05	0.000316	CbGpPWpGaD
Sulindac—PTGS2—Disease—CALCA—migraine	3.83e-05	0.0003	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—TNF—migraine	3.82e-05	0.0003	CbGpPWpGaD
Sulindac—MAPK3—Immune System—FOS—migraine	3.66e-05	0.000287	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TGFBR2—migraine	3.64e-05	0.000285	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CACNA1A—migraine	3.59e-05	0.000282	CbGpPWpGaD
Sulindac—PTGS2—Disease—TGFBR2—migraine	3.09e-05	0.000242	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—HTR2A—migraine	2.96e-05	0.000232	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—MTHFR—migraine	2.65e-05	0.000207	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—ESR1—migraine	2.62e-05	0.000206	CbGpPWpGaD
Sulindac—PTGS2—Disease—MTHFR—migraine	2.51e-05	0.000197	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—MTHFR—migraine	2.1e-05	0.000165	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—MTHFR—migraine	1.86e-05	0.000146	CbGpPWpGaD
Sulindac—ALB—Metabolism—MTHFR—migraine	1.7e-05	0.000133	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—MTHFR—migraine	1.19e-05	9.31e-05	CbGpPWpGaD
